Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation

BACKGROUND: A recent randomized phase III study of 719 de novo liver transplant recipients showed that early everolimus plus reduced-dose tacrolimus (EVR + rTAC) led to significantly better kidney function than standard TAC (TAC-C), without compromising efficacy. In that study, patients from North A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, William C., Brown, Robert S., Chavin, Kenneth D., Sudan, Debra, Koneru, Baburao, Junge, Guido, Dong, Gaohong, Patel, Dharmesh, Teperman, Lewis, Fung, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Clinical Science—Liver
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265688/
https://www.ncbi.nlm.nih.gov/pubmed/28121741
http://dx.doi.org/10.1097/TP.0000000000001524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265688/
https://www.ncbi.nlm.nih.gov/pubmed/28121741
http://dx.doi.org/10.1097/TP.0000000000001524

Ejemplares similares